Press Releases

Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology

PARSIPPANY, N.J., Feb. 12, 2026 /PRNewswire/ -- Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, today announced the enrollment of the first patient in its Post-Market Surveillance Study of the ELEOS Limb Salvage System with NanoCept Antibacterial Implant Technology. This first and only orthopaedic antibacterial coating technology available on...

Learn More

Onkos Surgical® Opens New Innovation Center for NanoCept® Antibacterial Technology

PARSIPPANY, N.J., Dec. 10, 2025 /PRNewswire/ -- Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, has opened the NanoCept Innovation Center, a new facility in Bridgewater Township, NJ. Onkos Surgical Ribbon Cutting (Featured left to right): Erin D’Auria, John Coelho, Gene Kulesha, Dr. Steven Gitelis, Michael Kirsh, Patrick...

Learn More

Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology

PARSIPPANY, N.J., Oct. 21, 2025 /PRNewswire/ -- Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, announced that it has recently received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ELEOS Proximal Tibia with NanoCept Antibacterial Technology. This marks the first 510(k) clearance for...

Learn More

Onkos NanoCept™ Antibacterial technology featured in BoneZone

Checking in on Exciting Advancements in Antimicrobial Implants by Dan Cook on Nov 26, 2024 There’s no doubt that infections related to contaminated orthopedic implants are serious complications that need to be addressed. However, industry stakeholders might not fully grasp the troubling extent of the issue. Patrick Treacy, Founder and CEO of...

Learn More

Onkos Surgical® Successfully Completes Groundbreaking, First-in-Human Cases Using NanoCept™ Antibacterial Technology

Parsippany, NJ – January 9, 2025 – Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, today announced that its revolutionary NanoCept Antibacterial Technology has been used successfully in multiple surgical procedures. NanoCept is a novel antibacterial coating applied to orthopaedic implants to help address intraoperative bacterial...

Learn More

Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology

Farmington, Connecticut – January 8, 2025 – Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon” or the “Company”), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services,...

Learn More

Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients. PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ -- Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor,...

Learn More

Onkos Surgical Announces Expanded Capability in Pediatric Musculoskeletal Oncology and Unveils New Manufacturing and Innovation Center

Company expands capabilities of its Precision Orthopaedics platform PARSIPPANY, N.J., July 19, 2023 /PRNewswire/ -- Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, announced its launch of the JTS Extendible Prosthesis, a novel growing implant designed for pediatric patients with bone cancer, and unveiled its new, state-of-the-art...

Learn More

Onkos Surgical Receives FDA 510(K) Clearance For 3D Printed, Patient-Specific Pelvic Reconstruction System

Company expands its portfolio of musculoskeletal oncology and complex orthopaedic solutions to include conditions of the pelvis PARSIPPANY, N.J., July 14, 2022 /PRNewswire/ — Onkos Surgical, a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received 510(k) clearance for its...

Learn More

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis

Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer PARSIPPANY, N.J., June 13, 2022 /PRNewswire/ — Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the...

Learn More